Quant Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1208 Cr | ₹402 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹1000 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 28 Dec 2015 | 17 Jun 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare TRI |
Turn Over | 26.49% | % |
Expense Ratio | 2.14 | 2.39 |
Manager | Meeta Shetty | Sanjeev Sharma |
ISIN Code | INF277K016A9 | INF966L01CG3 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Month | 2.48% | 3.63% |
6 Month | -3.08% | -9.69% |
1 Year | 16.58% | 5.6% |
3 Year | 20.32% | - |
5 Year | 22.02% | - |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
6 Month | 0.81% | -0.63% |
1 Year | 3.58% | -8.83% |
3 Year | 24.72% | - |
5 Year | 20.05% | - |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Year | 7.82% | 55.41% |
3 Year | 17.79% | - |
5 Year | 14.55% | - |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Standard Deviation | 16.538% | - |
Sharp | 0.681% | - |
Beta | 0.969% | - |
Alpha | 0.018% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Name | Meeta Shetty | Sanjeev Sharma |
Total AUM | ₹17847 Cr | ₹39731 Cr |
Funds Managed | 5 | 22 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 5.06 | 3.06 |
Small Cap | 27.82 | 52.32 |
Large Cap | 35.26 | 30.87 |
Mid Cap | 31.87 | 13.75 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 4.34 | 3.06 |
Basic Materials | 2.22 | - |
Healthcare | 93.44 | 79.02 |
Energy | - | 6.71 |
Technology | - | 5.45 |
Consumer Defensive | - | 5.77 |
Top Comparisons
SBI Magnum Low Duration Fund - Regular Plan - Growth
3Y Returns6.61%
Canara Robeco Savings Fund - Regular Plan - Growth Option
3Y Returns6.71%
Aditya Birla Sun Life India Gennext Fund-Growth Option
3Y Returns16.03%
UTI India Consumer Fund - Regular Plan - Growth Option
3Y Returns13.47%
Nippon India Equity Hybrid Fund - Growth Plan
3Y Returns15.11%
PGIM India Hybrid Equity Fund - Growth Option
3Y Returns12.04%
BANDHAN Balanced Advantage Fund Regular Plan Growth
3Y Returns10.23%
HSBC Balanced Advantage Fund - Regular Growth
3Y Returns11.02%